UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Population Pharmacokinetics of Fluconazole in Young Infants

Antimicrobial Agents and Chemotherapy, 2008-11, Vol.52 (11), p.4043-4049

2008

Volltextzugriff (PDF)

Population pharmacokinetics of ε-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery

British journal of anaesthesia : BJA, 2015-04, Vol.114 (4), p.689-699

2015

Volltextzugriff (PDF)

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

Alimentary pharmacology & therapeutics, 2015-07, Vol.42 (2), p.188-202

2015

Volltextzugriff (PDF)

Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery

British journal of anaesthesia : BJA, 2013-05, Vol.110 (5), p.788-799

2013

Volltextzugriff (PDF)

Mathematics for Understanding Disease

Clinical pharmacology and therapeutics, 2008-06, Vol.83 (6), p.904-908

2008

Volltextzugriff (PDF)

Quantitative Assessment of Exposure-Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

Clinical pharmacology and therapeutics, 2010-03, Vol.87 (3), p.336-344

2010

Volltextzugriff (PDF)

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model

CPT: pharmacometrics and systems pharmacology, 2015-09, Vol.4 (9), p.527-536

2015

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years

Journal of clinical pharmacology, 2011-03, Vol.51 (3), p.333-345

2011

Volltextzugriff (PDF)

Population Pharmacokinetics of Ciprofloxacin in Pediatric Patients

Journal of clinical pharmacology, 2003-07, Vol.43 (7), p.698-710

2003

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

Clinical pharmacology and therapeutics, 2018-06, Vol.103 (6), p.1029-1037

2018

Volltextzugriff (PDF)

The use of multiple doses and pharmacodynamic system analysis to distinguish between dispositional delays and time-variant pharmacodynamics

Pharmaceutical research, 1994-12, Vol.11 (12), p.1825-1828

1994

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia

Journal of pharmacokinetics and pharmacodynamics, 2001-12, Vol.28 (6), p.555-575

2001

Volltextzugriff (PDF)

Pharmacometrics as a Discipline Is Entering the "Industrialization" Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.9S-19S

2010

Volltextzugriff (PDF)

Missing Data in Model-Based Pharmacometric Applications: Points to Consider

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.63S-74S

2010

Volltextzugriff (PDF)

Effect of NONMEM minimization status and number of replicates on bootstrap parameter distributions for population pharmacokinetic models: A case study

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P2-P2

2005

Volltextzugriff (PDF)

Evaluation of the effect of residual error covariance for a parent-metabolite population pharmacokinetic model

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P91-P91

2005

Volltextzugriff (PDF)

Defining the Future of Pharmacometrics: The American Society of Pharmacometrics

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.158S-158S

2010

Volltextzugriff (PDF)

Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility

Immunopharmacology, 1992-03, Vol.23 (2), p.117-124

1992

Volltextzugriff (PDF)

Population pharmacokinetic-pharmacodynamic modeling of efaproxiral in cancer patients receiving radiation therapy

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P89-P89

2005

Volltextzugriff (PDF)

ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.7S-8S

2010

Volltextzugriff (PDF)

Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers

Drug discoveries & therapeutics, 2010-02, Vol.4 (1), p.44-53

2010

Volltextzugriff (PDF)

Population Pharmacokinetics of Theophylline and Metabolite Caffeine in Premature Infants Treated For Apnea

Clinical pharmacology and therapeutics, 2003-02, Vol.73 (2), p.P84-P84

2003

Volltextzugriff (PDF)

Application of a map Bayesian method for CYP2E1 phenotyping

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P41-P41

2004

Volltextzugriff (PDF)

Nonlinear mixed effects modeling of time dependencies in drug-free ECG data from healthy volunteers

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P97-P97

2004

Volltextzugriff (PDF)

Concentration-QTC modeling in healthy volunteers (HV) and in subjects with major depressive disorder (MDD) for a novel antidepressant candidate

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P88-P88

2004

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(56)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetics of Fluconazole in Young Infants

Population pharmacokinetics of ε-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery

Mathematics for Understanding Disease

Quantitative Assessment of Exposure-Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model

Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years

Population Pharmacokinetics of Ciprofloxacin in Pediatric Patients

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

The use of multiple doses and pharmacodynamic system analysis to distinguish between dispositional delays and time-variant pharmacodynamics

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia

Pharmacometrics as a Discipline Is Entering the "Industrialization" Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success

Missing Data in Model-Based Pharmacometric Applications: Points to Consider

Effect of NONMEM minimization status and number of replicates on bootstrap parameter distributions for population pharmacokinetic models: A case study

Evaluation of the effect of residual error covariance for a parent-metabolite population pharmacokinetic model

Defining the Future of Pharmacometrics: The American Society of Pharmacometrics

Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility

Population pharmacokinetic-pharmacodynamic modeling of efaproxiral in cancer patients receiving radiation therapy

ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics

Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers

Population Pharmacokinetics of Theophylline and Metabolite Caffeine in Premature Infants Treated For Apnea

Application of a map Bayesian method for CYP2E1 phenotyping

Nonlinear mixed effects modeling of time dependencies in drug-free ECG data from healthy volunteers

Concentration-QTC modeling in healthy volunteers (HV) and in subjects with major depressive disorder (MDD) for a novel antidepressant candidate

Suchergebnisse filtern